Screener Summaries Updates Institutions Sign In More Updates › Earnings › ELV Earnings · Mar 10, 2026
Elevance Health reaffirmed its 2026 full-year guidance, projecting adjusted shareholders' earnings of at least $25.50… ELV Elevance Health, Inc.
Elevance Health reaffirmed its 2026 full-year guidance, projecting adjusted shareholders' earnings of at least $25.50 per diluted share and a benefit expense ratio of 90.2% plus or minus 50 basis points. This guidance incorporates the potential impact of intermediate sanctions from CMS regarding the company's Medicare Advantage-Prescription Drug plans.
More from Elevance Health, Inc. Elevance Health raises full-year adjusted diluted EPS guidance to at least $29.00 on operating momentum Oct 21, 2026 Elevance Health reaffirmed its full-year 2026 earnings guidance during investor meetings, projecting at least $20.10… Sep 10, 2026 Elevance Health, Inc. issued a press release on July 15, 2026, reporting its financial results for the quarter ended… Jul 15, 2026 Elevance Health, Inc. reaffirmed its full year 2026 shareholders' earnings guidance of at least $19.85 per diluted… Jun 10, 2026 Elevance Health, Inc. held its annual meeting of shareholders on May 13, 2026, resulting in the election of three… May 13, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
